Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous …
V Milovanov, A Sardi, P Ledakis, N Aydin… - European Journal of …, 2015 - Elsevier
Background The role of SC before CRS/HIPEC for patients with PMCA is unclear. This study
explores the effect of SC prior to CRS/HIPEC on overall survival (OS) in patients with PMCA …
explores the effect of SC prior to CRS/HIPEC on overall survival (OS) in patients with PMCA …
The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal …
H El Halabi, V Gushchin, J Francis, N Athas… - Annals of surgical …, 2012 - Springer
Background Patients with peritoneal mucinous carcinomatosis (PMCA) of appendiceal
origin and extensive disease are commonly advised against CRS/HIPEC. We hypothesize …
origin and extensive disease are commonly advised against CRS/HIPEC. We hypothesize …
Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma …
CA Munoz-Zuluaga, MC King, P Ledakis… - European Journal of …, 2019 - Elsevier
Background The role of systemic chemotherapy (SC) before cytoreductive surgery and
hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in appendiceal high-grade …
hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in appendiceal high-grade …
Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal …
AU Blackham, K Swett, C Eng… - Journal of surgical …, 2014 - Wiley Online Library
Background The role of systemic chemotherapy (SC) in conjunction with cytoreductive
surgery (CS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in appendiceal …
surgery (CS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in appendiceal …
The 7th edition of the AJCC staging classification correlates with biologic behavior of mucinous appendiceal tumor with peritoneal metastases treated with …
V Milovanov, A Sardi, K Studeman, C Nieroda… - Annals of surgical …, 2016 - Springer
Purpose We evaluated the 7th edition of the American Joint Committee on Cancer (AJCC)
staging classification in terms of overall survival (OS) in patients with PMP treated with …
staging classification in terms of overall survival (OS) in patients with PMP treated with …
Hyperthermic intraperitoneal chemotherapy following cytoreductive surgery improves outcome in patients with primary appendiceal mucinous adenocarcinoma: a …
WL Shaib, LK Martin, M Choi, Z Chen, K Krishna… - The …, 2015 - academic.oup.com
Purpose. Appendiceal mucinous neoplasms (AMN) are a rare heterogeneous group of
diseases. In the absence of randomized trials, AMN management is controversial. The goal …
diseases. In the absence of randomized trials, AMN management is controversial. The goal …
Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience
DA Schomas, RC Miller, JH Donohue, S Gill… - Annals of …, 2009 - journals.lww.com
Objective: To determine prognostic factors and the impact of intraperitoneal (IP) treatment
after surgical resection of peritoneal mucinous carcinomatosis (PMC) of appendiceal origin …
after surgical resection of peritoneal mucinous carcinomatosis (PMC) of appendiceal origin …
Iterative cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent mucinous adenocarcinoma of the appendix
F Lopez-Ramirez, V Gushchin, M Sittig… - Annals of Surgical …, 2022 - Springer
Background Recurrence after cytoreductive surgery (CRS) with hyperthermic intraperitoneal
chemotherapy (HIPEC) for appendiceal tumors (AT) with mucinous carcinomatosis peritonei …
chemotherapy (HIPEC) for appendiceal tumors (AT) with mucinous carcinomatosis peritonei …
Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin
Background A treatment option for patients with peritoneal mucinous carcinomatosis
(PMCA) from an appendiceal neoplasm is cytoreductive surgery and perioperative …
(PMCA) from an appendiceal neoplasm is cytoreductive surgery and perioperative …
Systemic chemotherapy prior to cytoreductive surgery and HIPEC for carcinomatosis from appendix cancer: Impact on perioperative outcomes and short‐term survival
L Bijelic, AS Kumar, OA Stuart… - … research and practice, 2012 - Wiley Online Library
Background and Objectives. Systemic chemotherapy administered prior to cytoreductive
surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mucinous …
surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mucinous …
相关搜索
- systemic chemotherapy cytoreductive surgery
- systemic chemotherapy appendiceal origin
- cytoreductive surgery appendiceal origin
- mucinous carcinoma appendiceal origin
- systemic chemotherapy mucinous carcinoma
- cytoreductive surgery mucinous carcinoma
- cytoreductive surgery outcome in patients
- intraperitoneal treatment appendiceal origin
- consecutive patients appendiceal origin
- cytoreductive surgery peritoneal metastases
- operative management appendiceal origin
- folfox chemotherapy consecutive patients
- cytoreductive surgery pooled analysis
- cytoreductive surgery biologic behavior
- systemic chemotherapy perioperative outcomes
- cytoreductive surgery appendiceal carcinoma